Radioprotectors in radiotherapy – advances in the potential application of phytochemicals
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue
Abstract
Radiotherapy, in addition to chemotherapy, is currently the primary method of cancer treatment based on destruction of malignant cells by ionizing radiation. Unfortunately, it also affects normal cells, which is associated with negative consequences for a patient. Radioprotectors are compounds used to prevent/protect the non-tumor cells from the harmful effects of radiation. To play their role these compounds should meet several criteria; among others, they should significantly protect normal cells from radiation without changing the tumor cell radiosensitivity. In general, agents used to alter normal tissue toxicity from radiation can be broadly divided into three categories based on timing of delivery in relation to radiation: chemical radioprotectors, mitigators, and treatment. These groups include a diverse range of synthetic compounds in terms of their structure and protective mechanisms. The aminoradiothiol amifostine is the only radioprotectant approved in clinical application. However, its use is limited due to toxicity concerns (it may cause hypotension). Natural compounds, derived from plants, meet all criteria of the ideal radioprotector. They exert their protective actions against adverse effects of ionizing radiation by several mechanisms. Plant compounds that show radioprotective activity include flavonoids and phenolic acids, stilbenes, lycopene, alkaloids, peptides, polysaccharides, and phytohormones. Garlic, green tea, apples, citrus, and ginger are examples of constituents of the human diet that contain radioprotective substances.
Authors and Affiliations
Magdalena Szejk, Joanna Kołodziejczyk-Czepas, Halina Małgorzata Żbikowska
Keywords
Related Articles
- EP ID EP220811
- DOI -
- Views 138
- Downloads 0
Role of Th17 lymphocytes in pathogenesis of colorectal cancer
Colorectal cancer (CRC) is estimated to be the first leading cause of death from cancer among men and women in the EU. Every year in Poland, 15,254 cases of CRC are diagnosed, and 10,501 patients die of the disease, maki...
Reakcje anafilaktyczne na substancje chemiczne o małej masie cząsteczkowej
Substancje chemiczne o małej masie cząsteczkowej (hapteny) obejmują dużą grupę związków chemicznych znajdujących się w środowisku pracy, przedmiotach codziennego użytku (środki czystości, odzież, obuwie, rękawiczki, mebl...
Właściwości komórek macierzystych, regulacje prawne oraz zastosowanie w medycynie
Komórki macierzyste (stem cells -SC) cechuje unikalna zdolność do samoodnawiania i różnicowania w różne typy komórek, dlatego odgrywają istotną rolę w procesie regeneracji i naprawy. Izolowane z węzła zarodkowego blastoc...
Different pathways of macrophage activation and polarization
Monocytes are short-lived cells and undergo spontaneous apoptosis every day. Inflammatory responses may induce dramatic up-regulation of monocyte survival and differentiation. When monocytes are recruited to an area of i...
Aspekty biochemiczne i kliniczne zaawansowanych produktów utleniania białek w chorobach nerek i zaburzeniach metabolicznych
Wyniki licznych badań doświadczalnych potwierdzają nasilenie oksydacyjnych modyfikacji białek i wzrost stężenia zaawansowanych produktów utleniania białek (AOPPs) w różnych stanach patologicznych, szczególnie tych o dobr...